Literature DB >> 17442934

CD56 marks an effector T cell subset in the human intestine.

Offer Cohavy1, Stephan R Targan.   

Abstract

T cells are key mediators of intestinal immunity, and specific T cell subsets can have differing immunoregulatory roles in animal models of mucosal inflammation. In this study, we describe human CD56+ T cells as a morphologically distinct population expressing a mature, nonproliferative phenotype that is frequent in the gut. Enhanced potential for IFN-gamma and TNF synthesis suggested a proinflammatory function, and we directly demonstrate effector function mediated by direct T-T interaction with responder cells in vitro. CD56+ T cells from peripheral blood responded to the gut-related CD2 signal, and were necessary for effective CD2-mediated proliferation of peripheral blood CD56- T cells. Our findings associate CD56+ T cells with the intestinal immune compartment and suggest a putative effector function in human mucosal immunity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17442934     DOI: 10.4049/jimmunol.178.9.5524

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Isopentenyl pyrophosphate-activated CD56+ {gamma}{delta} T lymphocytes display potent antitumor activity toward human squamous cell carcinoma.

Authors:  Alan A Z Alexander; Amudhan Maniar; Jean-Saville Cummings; Andrew M Hebbeler; Dan H Schulze; Brian R Gastman; C David Pauza; Scott E Strome; Andrei I Chapoval
Journal:  Clin Cancer Res       Date:  2008-07-01       Impact factor: 12.531

2.  CD161 DEFINES EFFECTOR T CELLS THAT EXPRESS LIGHT AND RESPOND TO TL1A-DR3 SIGNALING.

Authors:  O Cohavy; D Q Shih; T M Doherty; C F Ware; S R Targan
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2011-03

Review 3.  Cellular and molecular mechanisms of memory T-cell survival.

Authors:  Andre Tanel; Simone G Fonseca; Bader Yassine-Diab; Rebeka Bordi; Joumana Zeidan; Yu Shi; Clarisse Benne; Rafick-Pierre Sékaly
Journal:  Expert Rev Vaccines       Date:  2009-03       Impact factor: 5.217

4.  Persistent changes in circulating and intestinal γδ T cell subsets, invariant natural killer T cells and mucosal-associated invariant T cells in children and adults with coeliac disease.

Authors:  Margaret R Dunne; Louise Elliott; Seamus Hussey; Nasir Mahmud; Jacinta Kelly; Derek G Doherty; Conleth F Feighery
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

5.  Potential role of NK cells in the pathogenesis of inflammatory bowel disease.

Authors:  Praveen K Yadav; Chi Chen; Zhanju Liu
Journal:  J Biomed Biotechnol       Date:  2011-06-01

Review 6.  Functionally Diverse NK-Like T Cells Are Effectors and Predictors of Successful Aging.

Authors:  Joshua J Michel; Patricia Griffin; Abbe N Vallejo
Journal:  Front Immunol       Date:  2016-11-24       Impact factor: 7.561

Review 7.  CD56 in the Immune System: More Than a Marker for Cytotoxicity?

Authors:  Heleen H Van Acker; Anna Capsomidis; Evelien L Smits; Viggo F Van Tendeloo
Journal:  Front Immunol       Date:  2017-07-24       Impact factor: 7.561

Review 8.  A narrative review of central nervous system involvement in acute leukemias.

Authors:  Dalma Deak; Nicolae Gorcea-Andronic; Valentina Sas; Patric Teodorescu; Catalin Constantinescu; Sabina Iluta; Sergiu Pasca; Ionut Hotea; Cristina Turcas; Vlad Moisoiu; Alina-Andreea Zimta; Simona Galdean; Jakob Steinheber; Ioana Rus; Sebastian Rauch; Cedric Richlitzki; Raluca Munteanu; Ancuta Jurj; Bobe Petrushev; Cristina Selicean; Mirela Marian; Olga Soritau; Alexandra Andries; Andrei Roman; Delia Dima; Alina Tanase; Olafur Sigurjonsson; Ciprian Tomuleasa
Journal:  Ann Transl Med       Date:  2021-01

9.  Analysis of Vδ1 T cells in clinical grade melanoma-infiltrating lymphocytes.

Authors:  Marco Donia; Eva Ellebaek; Mads Hald Andersen; Per Thor Straten; Inge Marie Svane
Journal:  Oncoimmunology       Date:  2012-11-01       Impact factor: 8.110

Review 10.  Tissue-Resident Lymphocytes Across Innate and Adaptive Lineages.

Authors:  Chun Chou; Ming O Li
Journal:  Front Immunol       Date:  2018-09-21       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.